Skip to main content

Advertisement

Vaccine and drug ontology in the study of mechanism and effect 2012 (VDOSME)

Vaccines and drugs have been critical to prevent and treat human and animal diseases. Vaccines and drugs are closely related in various aspects such as preclinical research and development, manufacturing, clinical trials, government approval and regulation, and post-licensure usage surveillance and monitoring. In a broader scope, vaccine is a special type of drug. Over the last decade, there have been efforts in biomedical ontology that represent various areas associated with vaccines and drugs, which join existing health and clinical terminology systems (e.g., SNOMED, RxNorm, NDF-RT, and MedDRA) in their applications to research and clinical data. This thematic series aims to provide a platform for discussing problems and solutions in the development and applications of biomedical ontologies to representing and analyzing vaccines/drugs, vaccine/drug administrations, vaccine/drug-induced immune responses, adverse events, and similar topics. Different computational methods, including literature mining of vaccine/drug-gene interaction networks, meta-analysis of host immune responses, time event analysis of adverse events, and Semantic Web applications, have been applied.

Prof Darrell Abernethy, Dr Gully Burns, Dr Yongqun He, Dr Cui Tao, Dr Luca Toldo

  1. Research

    GalenOWL: Ontology-based drug recommendations discovery

    Identification of drug-drug and drug-diseases interactions can pose a difficult problem to cope with, as the increasingly large number of available drugs coupled with the ongoing research activities in the pha...

    Charalampos Doulaverakis, George Nikolaidis, Athanasios Kleontas and Ioannis Kompatsiaris

    Journal of Biomedical Semantics 2012 3:14

    Published on: 20 December 2012

  2. Research

    Profiling structured product labeling with NDF-RT and RxNorm

    Structured Product Labeling (SPL) is a document markup standard approved by Health Level Seven (HL7) and adopted by United States Food and Drug Administration (FDA) as a mechanism for exchanging drug product i...

    Qian Zhu, Guoqian Jiang and Christopher G Chute

    Journal of Biomedical Semantics 2012 3:16

    Published on: 20 December 2012

  3. Research

    Extraction of potential adverse drug events from medical case reports

    The sheer amount of information about potential adverse drug events publishedin medical case reports pose major challenges for drug safety experts toperform timely monitoring. Efficient strategies for identifi...

    Harsha Gurulingappa, Abdul Mateen‐Rajpu and Luca Toldo

    Journal of Biomedical Semantics 2012 3:15

    Published on: 20 December 2012

Advertisement